Targeting Resistance Against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-1580
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
American Association for Cancer Research (AACR)